Teachers Retirement System of The State of Kentucky Makes New Investment in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)

Teachers Retirement System of The State of Kentucky purchased a new stake in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 298,000 shares of the company's stock, valued at approximately $7,420,000. Teachers Retirement System of The State of Kentucky owned approximately 0.05% of Fresenius Medical Care AG & Co. KGaA at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of FMS. Bank of New York Mellon Corp lifted its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 5.8% in the fourth quarter. Bank of New York Mellon Corp now owns 21,951 shares of the company's stock valued at $497,000 after purchasing an additional 1,205 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Fresenius Medical Care AG & Co. KGaA by 40.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 31,074 shares of the company's stock valued at $704,000 after buying an additional 8,913 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Fresenius Medical Care AG & Co. KGaA in the 4th quarter valued at $405,000. PNC Financial Services Group Inc. increased its stake in Fresenius Medical Care AG & Co. KGaA by 5.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 9,278 shares of the company's stock valued at $210,000 after buying an additional 442 shares during the last quarter. Finally, HighTower Advisors LLC increased its stake in Fresenius Medical Care AG & Co. KGaA by 7.9% in the 4th quarter. HighTower Advisors LLC now owns 17,890 shares of the company's stock valued at $405,000 after buying an additional 1,305 shares during the last quarter. 8.37% of the stock is currently owned by institutional investors.

Fresenius Medical Care AG & Co. KGaA Price Performance

Shares of Fresenius Medical Care AG & Co. KGaA stock traded down $0.39 on Friday, reaching $26.37. 83,946 shares of the stock were exchanged, compared to its average volume of 362,721. The firm's 50 day moving average is $28.05 and its 200-day moving average is $25.60. The firm has a market cap of $15.47 billion, a PE ratio of 23.54, a P/E/G ratio of 0.58 and a beta of 0.87. Fresenius Medical Care AG & Co. KGaA has a one year low of $17.93 and a one year high of $30.46. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.08 and a current ratio of 1.46.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.43 by $0.01. Fresenius Medical Care AG & Co. KGaA had a return on equity of 6.25% and a net margin of 3.18%. The company had revenue of $5.54 billion during the quarter, compared to analysts' expectations of $4.71 billion. As a group, analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 1.51 EPS for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The company also recently disclosed an annual dividend, which was paid on Friday, June 6th. Stockholders of record on Friday, May 23rd were given a dividend of $0.7871 per share. The ex-dividend date was Friday, May 23rd. This is a boost from Fresenius Medical Care AG & Co. KGaA's previous annual dividend of $0.44. This represents a dividend yield of 1.9%. Fresenius Medical Care AG & Co. KGaA's dividend payout ratio is 50.89%.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on FMS. Morgan Stanley reiterated an "underweight" rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Thursday, May 15th. Truist Financial lifted their price target on shares of Fresenius Medical Care AG & Co. KGaA from $25.00 to $30.00 and gave the company a "hold" rating in a research note on Monday, May 12th. Finally, Wall Street Zen raised shares of Fresenius Medical Care AG & Co. KGaA from a "hold" rating to a "strong-buy" rating in a research report on Saturday, July 5th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $27.80.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.